Advertisement
  • Forward Look

    The Avastin Roller Coaster

    Ups and downs keep coming for Avastin as studies report on its effects for different cancers.

    by Sue Rochman

  • Clinical Trials Game-Changer?

    A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?

    by Sue Rochman

  • Cancer In America

    Standard of Care

    Research suggests that black patients, as a whole, aren't receiving the same level of treatment as white patients. Can building better bonds between doctors and patients help?

    by Charlotte Huff

  • The HPV Cancer Connection: Take 2

    New insights about HPV's role in multiple cancers are rapidly expanding, as are thoughts about who should be vaccinated against the virus, and why.

    by Alanna Kennedy-Gorman

  • Forward Look

    Boosting Defenses Against Cancer

    Q&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.

    by Ingfei Chen

  • Forward Look

    Second-Cancer Clues?

    Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.

    by Mitzi Baker

  • Forward Look

    A Burning Question for Smokers

    Is the considerable risk-reduction benefit of CT screening worth the potential downsides?

    by Sue Rochman

  • Forward Look

    Getting Personal

    Health care experts push for care that focuses on the patient.

    by Alanna Kennedy-Gorman

  • Forward Look

    Avastin’s Fate

    Debate goes on as FDA revokes drug's use for breast cancer.

    by Alanna Kennedy-Gorman

  • Staying the Course

    Patients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.

    by Melissa Weber